Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Tumors
Interventions
DRUG

AMG 386

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00102830 - Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter